Evidence for postjunctional serotonin (5‐HT1) receptors in the trigeminocervical complex

@article{Goadsby2001EvidenceFP,
  title={Evidence for postjunctional serotonin (5‐HT1) receptors in the trigeminocervical complex},
  author={P. Goadsby and S. Akerman and R. Storer},
  journal={Annals of Neurology},
  year={2001},
  volume={50}
}
Units linked to stimulation of the superior sagittal sinus were identified and recorded from in the trigeminocervical complex of the anesthetized cat. Iontophoresis of glutamate NMDA receptor agonists increased the baseline‐firing rate of these neurons. Coejection of sumatriptan, 4991W93, or ergometrine resulted in a significant reduction in NMDA agonist‐induced increases in firing. These data establish the existence of triptan‐sensitive (5‐HT1) receptors on postsynaptic central trigeminal… Expand
Involvement of kainate glutamate receptors in the modulation of neuronal transmission in brain areas involved in migraine pathophysiology
Migraine pathophysiology is thought to involve activation of the trigeminal fibres which innervate dural structures. The nociceptive inflow from the meninges is relayed to the trigeminocervicalExpand
Effects of sumatriptan on rat medullary dorsal horn neurons
TLDR
The data suggest that sumatriptan acts pre‐synaptically on trigeminal primary afferent central terminals to reduce the probability of release of glutamate, and that this action is mediated through 5HT1D receptors. Expand
Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms
TLDR
The data suggest that the serotonergic and dopaminergic antinociceptive pathways act simultaneously on neurons in the trigeminocervical complex, and both amine systems need to be functioning for trigeminal sensitization to be reversed. Expand
Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex
TLDR
It is found that μ‐receptors modulate nociceptive input to the trigeminocervical complex and local iontophoresis of DAMGO during stimulation of the superior sagittal sinus resulted in a reduction in SSS‐evoked activity. Expand
Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity
TLDR
It is reported that nitroglycerine triggers cranial allodynia alongside migraine-like headache in patients, and dural-intracranial trigeminal neuronal hypersensitivity in rats, with both responding to abortive treatments. Expand
Calcitonin gene‐related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat
TLDR
The data suggest that there are non‐presynaptic C GRP receptors in the trigeminocervical complex that can be inhibited by CGRP receptor blockade and that a CgrP receptor antagonist would be effective in the acute treatment of migraine and cluster headache. Expand
Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input
TLDR
5-HT(1B) receptor-mediated inhibition is the most potent of the three in terms of inhibition of trigeminovascular nociceptive traffic. Expand
Functional Anatomy of Trigeminovascular Pain
TLDR
The term “trigeminovascular system” has been formed to describe the close morpho-functional relationship of trigeminal afferents with intracranial blood vessels, originally in the context of vascular headaches (Moskowitz, 1984). Expand
Tissue Injury Regulates Serotonin 1D Receptor Expression: Implications for the Control of Migraine and Inflammatory Pain
TLDR
It is suggested that a “pain”-triggered regulation of 5-HT1D-receptor expression underlies the effectiveness of triptans for the treatment of migraine, and the widespread expression of5- HT1D receptor in somatic nociceptive afferents suggests that triptan could, in certain circumstances, treat pain in nontrigeminal regions of the body. Expand
The role of serotonin receptors in migraine headaches
TLDR
The data on the distinctive distribution of different 5-HT receptors in the trigemino-vascular system and their involvement in the regulation of cerebral vascular tone, as well as in the modulation of pain transmission in peripheral and central structures of the trigEMinal complex are summarized. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 17 REFERENCES
Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5ht 1b/1D receptor: A central action in migraine?
TLDR
Data indicate that 5HT inhibits evoked trigeminal nucleus firing via the 5HT 1B/1D receptor at which GRI127935 is an antagonist, which highlights the case for describing this class of headache as neurovascular headaches rather than vascular headaches, to recognize the implicit contribution of the trigeminovascular system to their pathophysiology. Expand
Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism.
TLDR
The fact that sumatriptan can inhibit trigeminal activation without its vascular effects suggests that drugs without a significant activity on blood vessels may be effective in the treatment of migraine. Expand
Trigeminovascular nociceptive transmission involves N-methyl-d-aspartate and non-N-methyl-d-aspartate glutamate receptors
TLDR
A clear preclinical role of glutamatergic mechanisms in primary headache syndromes is suggested, such as migraine and cluster headache, and trigeminovascular-evoked responses in the trigeminocervical complex are suggested. Expand
Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.
TLDR
These data demonstrate that the second order trigeminal nucleus synapse in the brainstem and upper cervical cord is the most likely site of action for brain penetrant anti-migraine drugs of the 5HT1B/1D class. Expand
Activation of the Trigeminovascular System by Mechanical Distension of the Superior Sagittal Sinus in The Cat
TLDR
In eight a-chloralose anaesthetized cats mechanical distension of the superior sagittal sinus with a small intraluminal device was used to activate single units in the dorsolateral C2 spinal cord, consistent with the view that migraine is not primarily a vascular disorder but requires at least humoral or neural facilitation. Expand
4991W93, a potent blocker of neurogenic plasma protein extravasation, inhibits trigeminal neurons at 5-hydroxytryptamine (5-HT1B/1D) agonist doses
TLDR
Data suggest that 4991W93 is only effective at modulating the trigeminocervical complex at 5-HT(1B/1D) agonist doses, to account for neurogenic dural plasma protein extravasation blockade in animal studies. Expand
The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis
TLDR
The results suggest that NMDA receptors provide a potential therapeutic target for cephalic pain (e.g. migraine) due to trigeminovascular activation from meningeal afferents. Expand
Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development.
TLDR
The present findings suggest the importance of developing selective 5-HT1D alpha receptor agonists as a strategy to reduce the risk of myocardial infarction and possibly stroke that complicates the acute treatment of migraine headache. Expand
The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater
TLDR
The results demonstrate an important action of GR43175 on neurogenic mechanisms in dural blood vessels and suggest that drugs useful in the treatment of acute vascular headaches may share a similar mechanism of action. Expand
The pharmacology of headache
TLDR
The pharmacology of the head pain systems, as they are known and as they might evolve, are explored in the context of both, the anatomy and physiology of trigeminovascular nociception and in the contexts of clinical questions, such as those of efficacy, headache recurrence and adverse events. Expand
...
1
2
...